Effect of Taxane Plus Platinum Regimens vs Doxorubicin Plus Cisplatin as Adjuvant Chemotherapy for Endometrial Cancer at a High Risk of Progression-Reference-Cited by-同舟云学术

Effect of Taxane Plus Platinum Regimens vs Doxorubicin Plus Cisplatin as Adjuvant Chemotherapy for Endometrial Cancer at a High Risk of Progression

Published:2019-06-01 Issue:6 Volume:5 Page:833
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Nomura Hiroyuki¹,Aoki Daisuke¹,Michimae Hirofumi²,Mizuno Mika³,Nakai Hidekatsu⁴,Arai Masahide⁵,Sasagawa Motoi⁶,Ushijima Kimio⁷,Sugiyama Toru⁸,Saito Motoaki⁹,Tokunaga Hideki¹⁰,Matoda Maki¹¹,Nakanishi Toru¹²,Watanabe Yoh¹²,Takahashi Fumiaki¹³,Saito Toshiaki¹⁴,Yaegashi Nobuo¹⁵,

Affiliation:

1. Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan

2. Division of Biostatistics, Department of Clinical Medicine, Kitasato University School of Pharmacy, Tokyo, Japan

3. Department of Gynecology, Aichi Cancer Center Hospital, Aichi, Japan

4. Department of Obstetrics and Gynecology, Kindai University Faculty of Medicine, Osaka, Japan

5. Department of Obstetrics and Gynecology, Kitasato University School of Medicine, Kanagawa, Japan

6. Department of Gynecology, Niigata Cancer Center Hospital, Niigata, Japan

7. Department of Obstetrics and Gynecology, Kurume University School of Medicine, Fukuoka, Japan

8. Department of Obstetrics and Gynecology, School of Medicine, Iwate Medical University, Iwate, Japan

9. Department of Obstetrics and Gynecology, Jikei University School of Medicine, Tokyo, Japan

10. Department of Gynecology, Tohoku University Hospital, Miyagi, Japan

11. Department of Gynecology, Cancer Institute Hospital, Japanese Foundation for Cancer Research Tokyo, Japan

12. Division of Obstetrics and Gynecology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Miyagi, Japan

13. Clinical Research, Innovation and Education Center, Tohoku University Hospital, Miyagi, Japan

14. Gynecology Service, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan

15. Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Miyagi, Japan

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

http:///jamaoncology/article-pdf/5/6/833/17667023/jamaoncology_nomura_2019_oi_190001.pdf

Reference35 articles.

1. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up.;Colombo;Int J Gynecol Cancer,2016

2. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma.;Creutzberg;Lancet,2000

3. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study.;Keys;Gynecol Oncol,2004

4. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis.;Blake;Lancet,2009

5. Adjuvant radiotherapy for stage I endometrial cancer: systematic review and meta-analysis.;Kong;Ann Oncol,2007

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic impact of the number of resected pelvic nodes in endometrial cancer: Japanese Gynecologic Oncology Group Study JGOG2043 post hoc analysis;Journal of Gynecologic Oncology;2025

2. Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin–paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial;Annals of Oncology;2024-08

3. Endometrial Cancer: 2023 Revised FIGO Staging System and the Role of Imaging;Cancers;2024-05-14

4. A carrier-free metal-phenolic network with enhanced ferroptosis-immunotherapy for overcoming tumor resistance and metastasis;Chemical Engineering Journal;2024-05

5. Identification and removal of unexpected proliferative off-target cells emerging after iPSC-derived pancreatic islet cell implantation;Proceedings of the National Academy of Sciences;2024-04-10